Postoperative Restrictions for Patients Undergoing Minimally Invasive Gynecologic Procedures
Launched by ANNA FRAPPAOLO · Mar 27, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different recovery plans affect women after they have minimally invasive gynecologic surgery, which is a type of surgery done with small incisions. Specifically, the researchers want to find out if allowing patients to return to their normal activities sooner, without strict limits, helps them recover better compared to following standard restrictions that keep them from doing much for two weeks after surgery.
To participate, women who are 18 years or older, can speak English (and eventually Spanish), and have had surgery using small 5-8 mm port sites may be eligible. During the trial, participants will fill out a short survey one week and two weeks after their surgery to share how they feel and how their recovery is going. It’s important to note that the trial is not yet recruiting participants, so women interested in this study will need to wait until it officially begins.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Greater than or equal to 18 years of age
- • English speaking (Spanish speaking to be added once appropriate forms are professionally translated and approved)
- • 5-8 mm port sites used during the surgery
- Exclusion Criteria:
- • Less than 18 years of age
- • Primary language other than English (or Spanish once forms are professionally translated and approved)
- • Use of port size \>8mm
About Anna Frappaolo
Anna Frappaolo is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, Frappaolo leads a team of experienced professionals who specialize in the design, implementation, and management of clinical trials across various therapeutic areas. By fostering collaboration with healthcare providers, regulatory bodies, and research institutions, Anna Frappaolo ensures adherence to the highest ethical standards and compliance with regulatory requirements, ultimately driving the development of safe and effective treatments for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Providence, Rhode Island, United States
Patients applied
Trial Officials
Christine Foley, MD
Principal Investigator
Care New England - Women and Infants Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported